Atlas Trials

Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes

Clinical trial NCT02372253 · COMPLETED

Trial details

NCT number
NCT02372253
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2015-02-01
Primary completion
2017-12-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.